Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...

Today, the American Diabetes Association® (ADA) announced a new suite of resources to support improved care for those living with obesity. The resources are part of a nationwide collaboration between ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

President Trump took to Truth Social this week to express his shock over rising rates of autism in the US. Doctors have ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

Plus: Covid mission creep; Oxfam on colonialism; blaming Boomers; life before plastic wrappers; and the exploits of the ...

President Trump’s health secretary nominee, Robert F. Kennedy Jr., on Wednesday said vaccines are a critical component of ...

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have ...

That’s still on the low side among affluent countries, although there are some large world economies with lower taxes than the US (this chart shows 2022 data because 2023 numbers aren’t available for ...

Hailey Bieber shared a photo of her husband, Justin Beiber, sleeping after he claimed someone hacked his Instagram and unfollowed her. NewsNation's Paula Froelich confirms the Beibers are still in a ...

It may also, as a result, impact how obesity drugs are prescribed. Wegovy and Zepbound are approved in the US for anyone with a BMI of 30 or more. The threshold is 27 for individuals with a ...